期刊
INTERNAL MEDICINE
卷 48, 期 12, 页码 1037-1039出版社
JAPAN SOC INTERNAL MEDICINE
DOI: 10.2169/internalmedicine.48.1990
关键词
pioglitazone; slowly progressive type 1 diabetes; PPAR-gamma; anti-GAD antibody
Although recent studies recommended that insulin should be administered to patients with slowly progressive type 1 diabetes, even those with non-insulin dependent status, patients prefer oral hypoglycemic agents to insulin injections. We report a slowly progressive type 1 diabetic patient whose insulin production was preserved for 4 years (Sigma C-peptide from 29.48 ng/mL to 24.58 ng/mL) using pioglitazone despite a high titer of anti- GAD antibody (GADA; 120.7 U/mL). This case suggests that pioglitazone might prevent or delay the loss of insulin secretion and insulin dependency in slowly progressive type 1 diabetic patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据